ENGN Q3 2023 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$6M

Net Income

-$5M

EPS (Diluted)

$-0.26

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$37,000

Balance Sheet

Total Assets

$136M

Total Liabilities

$12M

Stockholders' Equity

$124M

Cash & Equivalents

$269,138

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$6M	-$5M	-17.8%
Net Income	-$5M	-$7M	+30.0%